Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 50 results for barrett's

  1. Oesophagectomy: What is the effectiveness of endoscopic resection with or without adjuvant chemoradiotherapy and oesophagectomy for adults with T1b oesophageal adenocarcinoma?

    treatment. Source guidance details Comes from guidance Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and...

    Research recommendation
    Published
    9 March 2023

  2. Diagnostic accuracy of endoscopic surveillance: What is the diagnostic accuracy of different endoscopic surveillance techniques including high resolution endoscopy and chromoendoscopy for use in adults?

    techniques. Source guidance details Comes from guidance Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and...

    Research recommendation
    Published
    9 March 2023

  3. Endoscopic treatments: For adults with stage 1 oesophageal adenocarcinoma, what is the effectiveness of different endoscopic ablation techniques alone or in combination with endoscopic resection?

    adenocarcinoma). Source guidance details Comes from guidance Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and...

    Research recommendation
    Published
    9 March 2023

  4. Frequency and duration of endoscopic follow-up: What is the optimal frequency and duration of endoscopic follow-up for patients who have received endoscopic treatment for stage 1 oesophageal adenocarcinoma?

    treatment. Source guidance details Comes from guidance Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and...

    Research recommendation
    Published
    9 March 2023

  5. Oesophago-gastric cancer: assessment and management in adults (NG83)

    This guideline covers assessing and managing oesophago-gastric cancer in adults, including radical and palliative treatment and nutritional support. It aims to reduce variation in practice through better organisation of care and support, and improve quality of life and survival by giving advice on the most suitable treatments depending on cancer type, stage and location.

    NICE guideline
    Last updated
    4 July 2023
    View recommendations

    Sections for NG83

  6. Toripalimab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer ID6406

    In development Reference number: GID-TA11341 Expected publication date:  02 December 2026

    Technology appraisal guidance
    In development

  7. Minimally invasive oesophagectomy (HTG272)

    Evidence-based recommendations on minimally invasive oesophagectomy. This involves making small cuts or holes in the chest wall and inserting a camera and other instruments into the chest cavity to carry out the operation.

    HealthTech guidance
    Published
    28 September 2011
    View recommendations

    Sections for HTG272

  8. KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment (HTG694)

    Early value assessment (EVA) guidance on KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication.

    HealthTech guidance
    Published
    26 September 2023
    View recommendations

    Sections for HTG694

  9. Peptest for diagnosing gastro‑oesophageal reflux (MIB31)

    NICE has developed a medtech innovation briefing (MIB) on Peptest for diagnosing gastro-oesophageal reflux

    Medtech innovation briefing
    Published
    22 May 2015

  10. Barrett's oesophagus: ablative therapy (CG106)

    This guidance has been updated and replaced by NICE guideline NG231.

    Withdrawn guideline

  11. Balloon cryoablation for Barrett's oesophagus (IPG811)

    We have moved interventional procedures guidance 811 to become HealthTech guidance 767. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  12. Photodynamic therapy for Barrett's oesophagus (IPG350)

    Interventional procedures, IPG350 - Issued: June 2010 --> We have moved interventional procedures guidance 350 to become HealthTech guidance 223. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. Balloon cryoablation for Barrett's oesophagus (IPG682)

    This guidance has been updated and replaced by NICE interventional procedures guidance 811.

    Withdrawn guidance

  14. Epithelial radiofrequency ablation for Barrett's oesophagus (IPG344)

    Interventional procedures, IPG344 - Issued: May 2010 --> We have moved interventional procedures guidance 344 to become HealthTech guidance 219. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  15. Transperineal biopsy for diagnosing prostate cancer (HTG680)

    Evidence-based recommendations on transperineal biopsy for diagnosing prostate cancer.

    HealthTech guidance
    Published
    1 June 2023
    View recommendations

    Sections for HTG680